TANA FRUMENTO: Open Payments
NPI 1972644532 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,562 in 190 payments from 24 companies in 2025. Trend: 2023 $6,698 · 2024 $7,458 · 2025 $3,562
Food & beverage: $3,274Education: $288
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $576 |
| GENZYME CORPORATION | 13 | $387 |
| LEO Pharma Inc. | 23 | $311 |
| UCB, Inc. | 25 | $310 |
| ABBVIE INC. | 16 | $275 |
| Novartis Pharmaceuticals Corporation | 18 | $257 |
| E.R. Squibb & Sons, L.L.C. | 16 | $244 |
| Regeneron Healthcare Solutions, Inc. | 9 | $221 |
| Organon LLC | 11 | $208 |
| Amgen Inc. | 7 | $140 |
Products named: DUPIXENT, TREMFYA, Bimzelx, Sotyktu, COSENTYX, ADBRY, RINVOQ, OTEZLA.
Industry payments across AZ — which companies pay providers there.
